• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗诊断学实践的培训、认证和指南的重要性:澳大利亚的观点。

The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective.

机构信息

Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia.

Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.

出版信息

J Nucl Med. 2022 Jun;63(6):819-822. doi: 10.2967/jnumed.122.263996. Epub 2022 Apr 7.

DOI:10.2967/jnumed.122.263996
PMID:35393349
Abstract

In nuclear medicine, theranostics is a burgeoning development that is rapidly being implemented worldwide. There is an increasing need to provide a multidisciplinary framework to the practice of theranostics, ensuring that patients receive this treatment safely and are secure in the knowledge that their health-care practitioners are adequately trained. Nuclear medicine experts in Australia have taken the initiative of producing a set of theranostic guidelines relevant to Australian medical practice. These guidelines encompass specialist qualifications, patient care, radiopharmaceutical production, radiation safety, and dosimetry. We propose adaptation of these guidelines by other countries, and we promote standards of practice leading to optimal clinical outcomes for patients receiving theranostic treatments.

摘要

在核医学中,治疗诊断学是一个迅速在全球范围内得到应用的新兴领域。为了确保患者安全地接受这种治疗,并确信他们的医疗保健从业者接受了充分的培训,需要为治疗诊断学的实践提供一个多学科框架。澳大利亚的核医学专家已经主动制定了一套与澳大利亚医疗实践相关的治疗诊断学指南。这些指南包括专业资格、患者护理、放射性药物生产、辐射安全和剂量测定。我们建议其他国家采用这些指南,并促进实践标准,为接受治疗诊断学治疗的患者带来最佳的临床效果。

相似文献

1
The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective.治疗诊断学实践的培训、认证和指南的重要性:澳大利亚的观点。
J Nucl Med. 2022 Jun;63(6):819-822. doi: 10.2967/jnumed.122.263996. Epub 2022 Apr 7.
2
Guiding principles on the education and practice of theranostics.治疗诊断学教育与实践指导原则
Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2320-2331. doi: 10.1007/s00259-024-06657-2. Epub 2024 Mar 8.
3
Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs.应用治疗诊断偶联物进行放射剂量计算时的物理、化学和生物学意义。
Theranostics. 2022 Jan 1;12(1):232-259. doi: 10.7150/thno.62851. eCollection 2022.
4
Emerging Preclinical and Clinical Applications of Theranostics for Nononcological Disorders.治疗学在非肿瘤性疾病中的新兴临床前和临床应用。
PET Clin. 2021 Jul;16(3):429-440. doi: 10.1016/j.cpet.2021.03.009.
5
Theranostic approaches in nuclear medicine: current status and future prospects.核医学中的治疗诊断学方法:现状与未来展望。
Expert Rev Med Devices. 2020 Apr;17(4):331-343. doi: 10.1080/17434440.2020.1741348. Epub 2020 Mar 19.
6
Bench-to-Bedside Theranostics in Nuclear Medicine.核医学中的临床前至临床转化治疗学。
Curr Pharm Des. 2020;26(31):3804-3811. doi: 10.2174/1381612826666200218104313.
7
Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.核医学中的治疗学:精准肿瘤学时代新兴和再现的综合影像与治疗
Radiographics. 2020 Oct;40(6):1715-1740. doi: 10.1148/rg.2020200021.
8
SNMMI Clinical Trials Network Research Series for Technologists: An Introduction to Conducting Theranostic Clinical Trials.核医学与分子影像学会临床试验网络技术专家研究系列:治疗诊断临床试验介绍。
J Nucl Med Technol. 2024 Sep 5;52(3):184-191. doi: 10.2967/jnmt.123.266588.
9
General Concepts in Theranostics.治疗诊断学的一般概念。
PET Clin. 2021 Jul;16(3):313-326. doi: 10.1016/j.cpet.2021.03.010.
10
Joint EANM, SNMMI, and IAEA Enabling Guide: How to Set up a Theranostics Center.联合 EANM、SNMMI 和 IAEA 启用指南:如何建立治疗诊断中心。
J Nucl Med. 2022 Dec;63(12):1836-1843. doi: 10.2967/jnumed.122.264321. Epub 2022 Apr 21.

引用本文的文献

1
Multifactorial analysis of radiochemical purity in high-activity Lu-labeled theranostics: impact of precursor source, Lu form, and production parameters.高活性镥标记诊疗剂放射化学纯度的多因素分析:前体来源、镥形态及生产参数的影响
EJNMMI Radiopharm Chem. 2025 Jul 22;10(1):47. doi: 10.1186/s41181-025-00372-5.
2
Current Status and Future Perspectives of Nuclear Medicine in Prostate Cancer from Imaging to Therapy: A Comprehensive Review.从成像到治疗的前列腺癌核医学现状与未来展望:综述
Biomedicines. 2025 May 7;13(5):1132. doi: 10.3390/biomedicines13051132.
3
Theranostics and molecular imaging training in the arab world: present and prospects.
阿拉伯世界的治疗诊断学与分子成像培训:现状与前景
Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3491-3495. doi: 10.1007/s00259-024-06845-0.
4
Production and regulatory issues for theranostics.治疗诊断学的生产和监管问题。
Lancet Oncol. 2024 Jun;25(6):e260-e269. doi: 10.1016/S1470-2045(24)00041-X.
5
Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics.核医学和肿瘤放射药物科学的趋势:治疗时代的劳动力挑战和培训。
Lancet Oncol. 2024 Jun;25(6):e250-e259. doi: 10.1016/S1470-2045(24)00037-8.
6
Guiding principles on the education and practice of theranostics.治疗诊断学教育与实践指导原则
Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2320-2331. doi: 10.1007/s00259-024-06657-2. Epub 2024 Mar 8.
7
Formulating a national position statement and guide on modern theranostics in the Philippines.制定菲律宾现代治疗诊断学的国家立场声明和指南。
Asia Ocean J Nucl Med Biol. 2024;12(1):69-72. doi: 10.22038/AOJNMB.2023.72838.1508.
8
Theranostics in Developing Countries: Addressing Challenges and Potentials from Training to Practice.发展中国家的诊疗一体化:应对从培训到实践的挑战与潜力
World J Nucl Med. 2023 Sep 20;22(3):171-173. doi: 10.1055/s-0043-1774733. eCollection 2023 Sep.
9
Nuclear Medicine Training: Skills and Competencies Required for Practice in the 21st Century.核医学培训:21世纪实践所需的技能和能力
World J Nucl Med. 2023 May 22;22(2):75-77. doi: 10.1055/s-0043-1769588. eCollection 2023 Jun.
10
Radiotheranostics in oncology: current challenges and emerging opportunities.肿瘤放射治疗学:当前的挑战与新兴机遇。
Nat Rev Clin Oncol. 2022 Aug;19(8):534-550. doi: 10.1038/s41571-022-00652-y. Epub 2022 Jun 20.